Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Medidata Solutions, Inc.MDSO · Entity 154211 | EVP, Human Resources | February 24, 2017 | February 27, 2017 |
| PROKIDNEY CORP.PROK · Entity 5181 | Chief People Officer | January 16, 2023 | January 18, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Medidata Solutions, Inc.
Report date February 24, 2017 · Filed February 27, 2017 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
This filing explicitly reported no securities owned.
PROKIDNEY CORP.
Report date January 16, 2023 · Filed January 18, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Employee stock option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $8.43 · Expires 2033-01-16 | Direct | 185,000 |
Reported balance
After 2023-01-16 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2023-01-16 · Grant · Acquired 185,000 · Balance 185,000 F1: The option vests in substantially equal monthly installments over the four year period beginning on January 16, 2023. |
Filing footnotes · ownership attribution and instrument terms
F1: The option vests in substantially equal monthly installments over the four year period beginning on January 16, 2023.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 16, 2023 Filed Jan 18, 2023 21:14 UTC | PROKIDNEY CORP. PROK · Entity 5181 | GrantEmployee stock option (right to buy) · Derivative | 185,000 | $0.00 Strike: $8.43 | $0.00 |
DisclosureSEC source: 0001209191-23-003720 · doc4.xml · derivative · entry 1 Weger Mary · CIK 0001638460 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 185,000 Underlying: Class A Ordinary Shares · 185,000 shares Expires 2033-01-16 F1 · derivative.exercise_date: The option vests in substantially equal monthly installments over the four year period beginning on January 16, 2023. Read SEC document |
| December 01, 2022 Filed Jan 6, 2023 21:59 UTC | PROKIDNEY CORP. PROK · Entity 5181 | GrantEmployee stock option (right to buy) · Derivative | 450,000 | $0.00 Strike: $10.25 | $0.00 |
DisclosureSEC source: 0001209191-23-002376 · doc4.xml · derivative · entry 1 Weger Mary · CIK 0001638460 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 450,000 Underlying: Class A Ordinary Shares · 450,000 shares Expires 2032-12-01 F1 · derivative.exercise_date: The right to purchase common stock vests over four years as follows: 25% on December 1, 2023 and the remaining 75% in substantially equal monthly installments over a 36 month period beginning on December 1, 2023. Read SEC document |
| February 23, 2017 Filed Feb 27, 2017 18:06 UTC | Medidata Solutions, Inc. MDSO · Entity 154211 | GrantStock Options (right to buy) · Derivative | 27,911 | $0.00 Strike: $56.36 | $0.00 |
DisclosureSEC source: 0001453814-17-000037 · wf-form4_148823676232235.xml · derivative · entry 2 Weger Mary · CIK 0001638460 · EVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,911 Underlying: Common Stock · 27,911 shares Expires 2027-02-23 F3 · price: Granted as compensation for services. F2 · derivative.exercise_date: The options will vest as to 25% of the shares on February 23, 2018 and 1/36th of the remaining options will become exercisable each month thereafter for the next 36 months. Read SEC document |
| February 23, 2017 Filed Feb 27, 2017 18:06 UTC | Medidata Solutions, Inc. MDSO · Entity 154211 | GrantCommon Stock | 18,630 | $0.00 | $0.00 |
DisclosureSEC source: 0001453814-17-000037 · wf-form4_148823676232235.xml · nonDerivative · entry 1 Weger Mary · CIK 0001638460 · EVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,630 F1 · shares: Award of shares of restricted stock under the issuer's Second Amended & Restated 2009 Long-Term Incentive Plan (the "2009 LTIP") on February 23, 2017. The restrictions will lapse with respect to one-fourth of the shares on each of February 23, 2018, February 23, 2019, February 23, 2020, and February 23, 2021. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.